Partnerships
We strive to be the partner of choice for companies seeking to make their innovative medicines available in Canada.
With a proven track record of launching and successfully commercializing specialty and rare-disease therapies we further bring a strong understanding of, and can successfully navigate the Canadian regulatory, access and reimbursement environments.
We welcome opportunities that will benefit Canadian patients through our infrastructure, expertise, and footprint readily scalable to support and effectively make these available in Canada.
Areas of Interest
Ex-Canada specialty/rare disease treatments near to, or on, the market.
Non-promoted/deprioritized products from which Canadian patients can still benefit.
While therapy area agonistic, we have a preference for the cardiovascular, endocrine and/or metabolic space.
Our Partners
Ionis Pharmaceuticals
Like-minded and sound collaborations with a singular purpose and who together put patients first.
Looking to commercialize an innovative treatment in Canada?
Let’s discuss how CELYSTRA Pharma can help bring it to Canadian patients.